Skip to main content

Table 1 Clinopathologic characteristics of mPA patients

From: Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs

Variables

Total (n = 11,885)

Single Metastasis (n = 9425)

Multiple Metastases (n = 2460)

P value

Gender

   

0.089

 Male

6564 (55.2%)

5168 (54.8%)

1396 (56.7%)

0.089

 Female

5321 (44.8%)

4257 (45.2%)

1064 (43.3%)

 

Age (years)

   

0.174

  ≤ 65

5725 (48.2%)

4570 (48.5%)

1155 (47.0%)

 

  > 65

6160 (51.8%)

4855 (51.5%)

1305 (53.0%)

 

 Range (median)

19–100 (66)

19–100 (66)

21–96 (66)

 

Race

   

0.434

 White

9362 (78.8%)

7427 (78.8%)

1935 (78.7%)

 

 Black

1622 (13.6%)

1297 (13.8%)

325 (13.2%)

 

 Others

901 (7.6%)

701 (7.4%)

200 (8.1%)

 

Tumor location

   

< 0.001

 Head

3972 (33.4%)

3371 (35.8%)

601 (24.4%)

 

 Body/tail

4409 (37.1%)

3405 (36.1%)

1004 (40.8%)

 

 Others

3504 (29.5%)

2649 (28.1%)

855 (34.8%)

 

Marital status

   

0.549

 Married

6634 (55.8%)

5274 (56.0%)

1360 (55.3%)

 

 Unmarried/unknown

5251 (44.2%)

4151 (44.0%)

1100 (44.7%)

 

Grade

   

0.001

 Well/moderately differentiated

1308 (11.0%)

1089 (11.5%)

219 (8.9%)

 

 Poorly differentiated/undifferentiated

1439 (12.1%)

1148 (12.2%)

291 (11.8%)

 

 Unknown

9138 (76.9%)

7188 (76.3%)

1950 (79.3%)

 

Tumor size (mm)*

 Range (median)

0–950 (40)

0–900 (40)

0–950 (43)

 

Surgery

   

< 0.001

 No

11,335 (95.4%)

8948 (94.9%)

2387 (97.0%)

 

 Yes

550 (4.6%)

477 (5.1%)

73 (3.0%)

 

Chemotherapy

   

0.013

 No/unknown

5350 (45.0%)

4188 (44.4%)

1162 (47.2%)

 

 Yes

6535 (55.0%)

5237 (55.6%)

1298 (52.8%)

 

Radiotherapy

   

< 0.001

 No

11,270 (94.8%)

9061 (96.1%)

2209 (89.8%)

 

 Yes

615 (5.2%)

364 (3.9%)

251 (10.2%)

 

Metastatic sites

   

< 0.001

 Bone

1056

193

863

 

 Brain

111

21

90

 

 Liver

10,883

8523

2360

 

 lung

2678

688

1990

 

* 2723 cases missing.